ManayiASaeidniaSGohariARAbdollahiM. Methods for the discovery of new anti-aging products-targeted approaches. Expert Opin Drug Discov. 2014;9(4):383-405.
2.
KenyonCJ. The genetics of ageing. Nature. 2010;464(7288):504-512.
3.
ZhaoGGuoSSomelMKhaitovichP. Evolution of human longevity uncoupled from caloric restriction mechanisms. PLoS One. 2014;9(1):e84117.
4.
WillcoxDCScapagniniGWillcoxBJ. Healthy aging diets other than the Mediterranean: a focus on the Okinawan diet. Mech Ageing Dev. 2014;136-137:148-162.
5.
HarrisonDEStrongRSharpZD. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392-395.
6.
VerhaveJBoucherADandavinoR. The incidence, management, and evolution of rapamycin-related side effects in kidney transplant recipients. Clin Transplant. 2014;28(5):616-622.
7.
TimmersSAuwerxJSchrauwenP. The journey of resveratrol from yeast to human. Aging (Albany NY). 2012;4(3):146-158.
8.
RenaudSde LorgerilM. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339(8808):1523-1526.
9.
MullinGE. Red wine, grapes, and better health: resveratrol. Nutr Clin Pract. 2011;26(6):7223.
10.
WangBSunJLiX. Resveratrol prevents suppression of regulatory T-cell production, oxidative stress, and inflammation of mice prone or resistant to high-fat diet-induced obesity. Nutr Res. 2013;33(11):971-981.
11.
BoSCicconeGCastiglioneA. Anti-inflammatory and antioxidant effects of resveratrol in healthy smokers: a randomized, double-blind, placebo-controlled, cross-over trial. Curr Med Chem. 2013;20(10):1323-1331.
12.
Tomé-CarneiroJLarrosaMYáñez-GascónMJ. One-year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol Res. 2013;72:69-82.
13.
HowitzKTBittermanKJCohenHY. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003;425(6954):191-196.
14.
BauerJHGoupilSGarberGBHelfandSL. An accelerated assay for the identification of lifespan-extending interventions in Drosophila melanogaster. Proc Natl Acad Sci U S A. 2004;101(35):12980-12985.
15.
BassTMWeinkoveDHouthoofdKGemsDPartridgeL. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Ageing Dev. 2007;128(10):546-552.
16.
ValenzanoDRCellerinoA. Resveratrol and the pharmacology of aging: a new vertebrate model to validate an old molecule. Cell Cycle. 2006;5(10):1027-1032.
17.
BaurJAPearsonKJPriceNL. Resveratrol improves health and survival of mice on a high-calorie diet. Nature. 2006;444(7117):337-342.
18.
SembaRDFerrucciLBartaliB. Resveratrol levels and all-cause mortality in older community-dwelling adults. JAMA Intern Med. 2014;174(7):1077-1084.
19.
HarmanD. About “Origin and evolution of the free radical theory of aging: a brief personal history, 1954-2009”. Biogerontology. 2009;10(6):783.
20.
BagiZCsekoCTóthEKollerA. Oxidative stress-induced dysregulation of arteriolar wall shear stress and blood pressure in hyperhomocysteinemia is prevented by chronic vitamin C treatment. Am J Physiol Heart Circ Physiol. 2003;285(6):H2277-H2283.
21.
NikiENoguchiNTsuchihashiHGotohN. Interaction among vitamin C, vitamin E, and beta-carotene. Am J Clin Nutr. 1995;62(6 Suppl):1322S-1326S.
22.
ErnstIMPallaufKBendallJK. Vitamin E supplementation and lifespan in model organisms. Ageing Res Rev. 2013;12(1):365-375.
23.
LiuTSternARobertsLJMorrowJD. The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid. J Biomed Sci. 1999;6(4):226-235.
24.
KitaniKOsawaTYokozawaT. The effects of tetrahydrocurcumin and green tea polyphenol on the survival of male C57BL/6 mice. Biogerontology. 2007;8(5):567-573.
25.
StvolinskySAntipinMMeguroKSatoTAbeHBoldyrevA. Effect ocarnosine and its Trolox-modified derivatives on life span of Drosophila melanogaster. Rejuvenation Res. 2010;13(4):453-457.
26.
RistowMSchmeisserS. Extending life span by increasing oxidative stress. Free Radic Biol Med. 2011;51(2):327-336.
27.
Sadowska-BartoszIBartoszG. Effect of antioxidants supplementation on aging and longevity. Biomed Res Int. 2014;2014:404680.
28.
HercbergSEzzedineKGuinotC. Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr. 2007;137(9):2098-2105.
29.
BjelakovicGNikolovaDGluudLLSimonettiRGGluudC. Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA. 2007;297(8):842-857.
30.
MendelsohnARLarrickJW. Trade-offs between anti-aging dietary supplementation and exercise. Rejuvenation Res. 2013;16(5):419-426.
31.
ChedrauiPPérez-LópezFR. Nutrition and health during mid-life: searching for solutions and meeting challenges for the aging population. Climacteric. 2013;16(Suppl 1):85-95.
32.
van den BrandtPA. The impact of a Mediterranean diet and healthy lifestyle on premature mortality in men and women. Am J Clin Nutr. 2011;94(3):913-920.
33.
PanagiotakosDBChrysohoouCSiasosG. Sociodemographic and lifestyle statistics of oldest old people (>80 years) living in Ikaria island: the Ikaria study. Cardiol Res Pract. 2011;2011:679187.
34.
ChrysohoouCStefanadisC. Longevity and diet: myth or pragmatism?Maturitas. 2013;76(4):303-307.
SameforsMÖstgrenCJMölstadSLanneringCMidlövPTengbladA. Vitamin D deficiency in elderly people in Swedish nursing homes is associated with increased mortality. Eur J Endocrinol. 2014;170(5):667-675.
37.
ZittermannAIodiceSPilzSGrantWBBagnardiVGandiniS. Vitamin D deficiency and mortality risk in the general population: a meta-analysis of prospective cohort studies. Am J Clin Nutr. 2012;95(1):91-100.
38.
AutierPBoniolMPizotCMullieP. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2(1):76-89.
39.
SattlerFR. Growth hormone in the aging male. Best Pract Res Clin Endocrinol Metab. 2013;27(4):541-555.
40.
ValentiGDentiLMaggioM. Effect of DHEAS on skeletal muscle over the life span: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59(5):466-472.
41.
DeodatiAFerroliBBCianfaraniS. Association between growth hormone therapy and mortality, cancer and cardiovascular risk: systematic review and meta-analysis. Growth Horm IGF Res. 2014;24(4):105-111.
42.
ShoresMMMatsumotoAM. Testosterone, aging and survival: biomarker or deficiency. Curr Opin Endocrinol Diabetes Obes. 2014;21(3):209-216.
43.
YangDLiJYuanZLiuX. Effect of hormone replacement therapy on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLoS One. 2013;8(5):e62329.